Abstract: Disclosed are compounds and pharmaceutically acceptable salts, hydrates, solvates, prodrugs, stereoisomers, or tautomers thereof that may cause degradation of various proteins e.g., IKZF2 (Helios). Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds to treat diseases and disorders associated with Helios and which may benefit from Helios degradation.
Type:
Application
Filed:
October 15, 2021
Publication date:
February 1, 2024
Applicants:
DANA-FARBER CANCER INSTITUTE, INC., NEOMORPH, INC.
Inventors:
Hu Liu, Tinghu Zhang, Lyn Jones, Jianwei Che, Brian Bear, Whitney Petrilli